A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DCB-AD1 in Patients with Mild to Moderate Alzheimer Disease

2006-01-012024-05-15https://scholars.lib.ntu.edu.tw/handle/123456789/663592A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DCB-AD1 in Patients with Mild to Moderate Alzheimer Disease